Reactivation of a developmental Bmp2 signaling center is required for therapeutic control of the periosteal niche in the murine skeleton

  1. Valerie S Salazar
  2. Luciane P Capelo
  3. Claudio Cantù
  4. Dario Zimmerli
  5. Nehal Gosalia
  6. Steven Pregizer
  7. Karen Cox
  8. Satoshi Ohte
  9. Marina Feigenson
  10. Laura Gamer
  11. Jeffry S Nyman
  12. David J Carey
  13. Aris Economides
  14. Konrad Basler
  15. Vicki Rosen  Is a corresponding author
  1. Harvard School of Dental Medicine, United States
  2. Universidade Federal de São Paulo, Brazil
  3. University of Zürich, Switzerland
  4. Regeneron Pharmaceuticals, United States
  5. Vanderbilt University Medical Centre, United States
  6. Geisinger Health System, United States

Abstract

Two decades after signals controlling bone length were discovered, the endogenous ligands determining bone width remain unknown. We show that postnatal establishment of normal bone width in mice, as mediated by bone-forming activity of the periosteum, requires BMP signaling at the innermost layer of the periosteal niche. This developmental signaling center becomes quiescent during adult life. Its reactivation however, is necessary for periosteal growth, enhanced bone strength, and accelerated fracture repair in response to bone-anabolic therapies used in clinical orthopedic settings. Although many BMPs are expressed in bone, periosteal BMP signaling and bone formation require only Bmp2 in the Prx1-Cre lineage. Mechanistically, BMP2 functions downstream of Lrp5/6 pathway to activate a conserved regulatory element upstream of Sp7 via recruitment of Smad1 and Grhl3. Consistent with our findings, human variants of BMP2 and GRHL3 are associated with increased risk of fractures.

Data availability

The DiscoverEHR human dataset is published and publicly available at http://www.discovehrshare.com. Using search terms 'BMP2' and 'GRHL3' and a Bonferroni significance threshold of P < 1.86e-7 for 268,192 association results, we observed three significant associations for BMP2 and six significant associations for GRHL3.Mouse limb bud ChIP-sequencing data are available through ArrayExpress website https://www.ebi.ac.uk/arrayexpress and accession #E-MTAB-7652.

The following data sets were generated

Article and author information

Author details

  1. Valerie S Salazar

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2111-9313
  2. Luciane P Capelo

    Instituto de Ciência e Tecnologia, Universidade Federal de São Paulo, São José dos Campos, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  3. Claudio Cantù

    Institute for Molecular Life Sciences, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Dario Zimmerli

    Institute for Molecular Life Sciences, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Nehal Gosalia

    Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Steven Pregizer

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Karen Cox

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Satoshi Ohte

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Marina Feigenson

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Laura Gamer

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Jeffry S Nyman

    Department of Orthopaedic Surgery and Rehabilitation, Vanderbilt University Medical Centre, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. David J Carey

    Geisinger Health System, Danville, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Aris Economides

    Skeletal Diseases Therapeutic Focus Area, Regeneron Pharmaceuticals, Tarrytown, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6508-8942
  14. Konrad Basler

    Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  15. Vicki Rosen

    Department of Developmental Biology, Harvard School of Dental Medicine, Boston, United States
    For correspondence
    vicki_rosen@hsdm.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4029-1055

Funding

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR055904)

  • Vicki Rosen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Clifford J Rosen, Maine Medical Center Research Institute, United States

Ethics

Animal experimentation: In vivo experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals and were approved by the Harvard Medical Area Institutional Animal Care and Use Committee (protocol #04043 to Vicki Rosen).

Version history

  1. Received: September 27, 2018
  2. Accepted: February 6, 2019
  3. Accepted Manuscript published: February 8, 2019 (version 1)
  4. Version of Record published: February 22, 2019 (version 2)

Copyright

© 2019, Salazar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,205
    views
  • 375
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Valerie S Salazar
  2. Luciane P Capelo
  3. Claudio Cantù
  4. Dario Zimmerli
  5. Nehal Gosalia
  6. Steven Pregizer
  7. Karen Cox
  8. Satoshi Ohte
  9. Marina Feigenson
  10. Laura Gamer
  11. Jeffry S Nyman
  12. David J Carey
  13. Aris Economides
  14. Konrad Basler
  15. Vicki Rosen
(2019)
Reactivation of a developmental Bmp2 signaling center is required for therapeutic control of the periosteal niche in the murine skeleton
eLife 8:e42386.
https://doi.org/10.7554/eLife.42386

Share this article

https://doi.org/10.7554/eLife.42386

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup ... Christian Kroun Damgaard
    Research Article

    Circular RNAs represent a class of endogenous RNAs that regulate gene expression and influence cell biological decisions with implications for the pathogenesis of several diseases. Here, we disclose a novel gene-regulatory role of circHIPK3 by combining analyses of large genomics datasets and mechanistic cell biological follow-up experiments. Using time-course depletion of circHIPK3 and specific candidate RNA-binding proteins, we identify several perturbed genes by RNA sequencing analyses. Expression-coupled motif analyses identify an 11-mer motif within circHIPK3, which also becomes enriched in genes that are downregulated upon circHIPK3 depletion. By mining eCLIP datasets and combined with RNA immunoprecipitation assays, we demonstrate that the 11-mer motif constitutes a strong binding site for IGF2BP2 in bladder cancer cell lines. Our results suggest that circHIPK3 can sequester IGF2BP2 as a competing endogenous RNA (ceRNA), leading to target mRNA stabilization. As an example of a circHIPK3-regulated gene, we focus on the STAT3 mRNA as a specific substrate of IGF2BP2 and validate that manipulation of circHIPK3 regulates IGF2BP2-STAT3 mRNA binding and, thereby, STAT3 mRNA levels. Surprisingly, absolute copy number quantifications demonstrate that IGF2BP2 outnumbers circHIPK3 by orders of magnitude, which is inconsistent with a simple 1:1 ceRNA hypothesis. Instead, we show that circHIPK3 can nucleate multiple copies of IGF2BP2, potentially via phase separation, to produce IGF2BP2 condensates. Our results support a model where a few cellular circHIPK3 molecules can induce IGF2BP2 condensation, thereby regulating key factors for cell proliferation.

    1. Cell Biology
    2. Computational and Systems Biology
    N Suhas Jagannathan, Javier Yu Peng Koh ... Lisa Tucker-Kellogg
    Research Article

    Bats have unique characteristics compared to other mammals, including increased longevity and higher resistance to cancer and infectious disease. While previous studies have analyzed the metabolic requirements for flight, it is still unclear how bat metabolism supports these unique features, and no study has integrated metabolomics, transcriptomics, and proteomics to characterize bat metabolism. In this work, we performed a multi-omics data analysis using a computational model of metabolic fluxes to identify fundamental differences in central metabolism between primary lung fibroblast cell lines from the black flying fox fruit bat (Pteropus alecto) and human. Bat cells showed higher expression levels of Complex I components of electron transport chain (ETC), but, remarkably, a lower rate of oxygen consumption. Computational modeling interpreted these results as indicating that Complex II activity may be low or reversed, similar to an ischemic state. An ischemic-like state of bats was also supported by decreased levels of central metabolites and increased ratios of succinate to fumarate in bat cells. Ischemic states tend to produce reactive oxygen species (ROS), which would be incompatible with the longevity of bats. However, bat cells had higher antioxidant reservoirs (higher total glutathione and higher ratio of NADPH to NADP) despite higher mitochondrial ROS levels. In addition, bat cells were more resistant to glucose deprivation and had increased resistance to ferroptosis, one of the characteristics of which is oxidative stress. Thus, our studies revealed distinct differences in the ETC regulation and metabolic stress responses between human and bat cells.